![](https://images.squarespace-cdn.com/content/v1/62b1ecff6f1c5b1a93fa7a92/bed5334a-30be-4ba2-8212-2f2e51e6587c/fruit%26veg_general.jpeg)
Join the IMPEDE Trial
and help make diverticulitis treatments better.
The IMPEDE Trial is comparing how two eating patterns affect quality of life for people with diverticulitis, as well as how markers in blood and stool related to inflammation change.
You may be eligible to participate in the IMPEDE Trial if you:
have had an episode of diverticulitis in the past 18 months;
are willing to adjust your diet for one year;
are willing to fill out surveys about your experience; and
can return for two scheduled visits in Seattle over the course of your participation.
The IMPEDE Trial is a study affiliated with the CERTAIN research and implementation network. Learn more about CERTAIN at becertain.org.
The IMPEDE Trial (ClinicalTrials.gov ID NCT05681559) is funded by an award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (award #R01DK131694).